EarliTec Diagnostics

EarliTec Diagnostics is a digital health company making earlier identification and treatment for ASD and related disabilities accessible to children everywhere. Developed by leading researchers at Children’s Healthcare of Atlanta, Emory University School of Medicine and Yale University, EarliTec is pioneering development of biomarkers that help parents, providers and caregivers understand how a child is viewing the world. The company’s initial product, the EarliPoint® Evaluation for Autism Spectrum Disorder received breakthrough status from the FDA as it seeks to be the first objective, clinically validated measure of individual ASD status and severity in children as young as 16 months of age.